These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35663076)

  • 1. Successful treatment in one myelodysplastic syndrome patient with primary thrombocytopenia and secondary deep vein thrombosis: A case report.
    Liu WB; Ma JX; Tong HX
    World J Clin Cases; 2022 May; 10(14):4640-4647. PubMed ID: 35663076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in Treating Extensive Deep Vein Thrombosis with Severe Thrombocytopenia in Patients with Antiphospholipid Syndrome-A Follow-up of 2 Years.
    Wei LK; Sule AA
    Int J Angiol; 2024 Feb; 33(1):66-69. PubMed ID: 38352633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombectomy of a Complex Deep Vein Thrombosis: A Case Report.
    Shabbir T; Wade M; Das K; Nayyar R
    Cureus; 2023 Jan; 15(1):e33413. PubMed ID: 36751222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Portal Vein Thrombosis During Eltrombopag Treatment Concomitant Splenectomy for Immune Thrombocytopenia.
    Saito M; Morioka M; Izumiyama K; Mori A; Kondo T
    Cureus; 2021 Aug; 13(8):e17478. PubMed ID: 34589366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
    Mittelman M; Platzbecker U; Afanasyev B; Grosicki S; Wong RSM; Anagnostopoulos A; Brenner B; Denzlinger C; Rossi G; Nagler A; Garcia-Delgado R; Portella MSO; Zhu Z; Selleslag D
    Lancet Haematol; 2018 Jan; 5(1):e34-e43. PubMed ID: 29241762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.
    Kawano N; Hasuike S; Iwakiri H; Nakamura K; Ozono Y; Kusumoto H; Nagata K; Kikuchi I; Yoshida S; Kuriyama T; Yamashita K; Muranaka T; Kawaguchi T; Sata M; Okamura T; Ueda A; Shimoda K
    J Clin Exp Hematop; 2013; 53(2):151-5. PubMed ID: 23995112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.
    Poudel DR; Ghimire S; Dhital R; Forman DA; Warkentin TE
    Platelets; 2017 Sep; 28(6):614-620. PubMed ID: 28856946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical success and short-term results from mechanical thrombectomy for lower extremity iliofemoral deep vein thrombosis using a computer aided mechanical aspiration thrombectomy device.
    Robertson B; Neville E; Muck A; Broering M; Kulwicki A; Kuhn B; Recht M; Muck P
    J Vasc Surg Venous Lymphat Disord; 2022 May; 10(3):594-601. PubMed ID: 34823046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban.
    Manji F; Warkentin TE; Sheppard JI; Lee A
    Platelets; 2020; 31(1):124-127. PubMed ID: 31397594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.
    Oliva EN; Alati C; Santini V; Poloni A; Molteni A; Niscola P; Salvi F; Sanpaolo G; Balleari E; Germing U; Fenaux P; Stamatoullas A; Palumbo GA; Salutari P; Impera S; Avanzini P; Cortelezzi A; Liberati AM; Carluccio P; Buccisano F; Voso MT; Mancini S; Kulasekararaj A; Morabito F; Bocchia M; Cufari P; Spiriti MA; Santacaterina I; D'Errigo MG; Bova I; Zini G; Latagliata R
    Lancet Haematol; 2017 Mar; 4(3):e127-e136. PubMed ID: 28162984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.
    Svensson T; Chowdhury O; Garelius H; Lorenz F; Saft L; Jacobsen SE; Hellström-Lindberg E; Cherif H
    Eur J Haematol; 2014 Nov; 93(5):439-45. PubMed ID: 24853277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist.
    Shimizu K; Iiduka T; Sato S; Kiyokawa H; Nakagami T; Mikamo H; Kawazoe M; Takahashi M; Noro M
    Ther Clin Risk Manag; 2018; 14():377-383. PubMed ID: 29503557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual case of dengue shock syndrome complicated by ilio-femoral deep vein thrombosis; a case report.
    Ranasinghe KMIU; Dissanayaka D; Thirumavalavan K; Seneviratne M
    BMC Infect Dis; 2020 May; 20(1):335. PubMed ID: 32398134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with positive thrombus findings at ultrasonography in COVID-19 ward patients who underwent imaging for suspected deep vein thrombosis under prophylactic anticoagulation.
    Özhan A; Bastopcu M
    J Vasc Surg Venous Lymphat Disord; 2022 Jul; 10(4):811-817. PubMed ID: 35218956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left subclavian and right femoral vein thrombosis in a pregnant patient with antithrombin deficiency.
    Watanabe C; Ichiba T; Naito H
    J Cardiol Cases; 2018 Oct; 18(4):149-151. PubMed ID: 30279935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation for perioperative thromboprophylaxis in people with cancer.
    Matar CF; Kahale LA; Hakoum MB; Tsolakian IG; Etxeandia-Ikobaltzeta I; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009447. PubMed ID: 29993117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol.
    Ghaziri D; Dehaini H; Msheik M; Bahmad M; Zorkot M; Saad GA
    BMC Pharmacol Toxicol; 2023 Jan; 24(1):2. PubMed ID: 36639796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular Treatment of Thrombosis and Embolism.
    Goktay AY; Senturk C
    Adv Exp Med Biol; 2017; 906():195-213. PubMed ID: 27664152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.